Theodore Lagattuta

Phase II Study of Imatinib Mesylate Plus Hydroxyurea in Adults With Recurrent Glioblastoma Multiforme

David A. Reardon, Merrill J. Egorin, Jennifer A. Quinn et al. · Journal of Clinical Oncology · 2005 · 330 citations · Full text

Effect of St John's wort on imatinib mesylate pharmacokinetics

Reginald F. Frye, Sara M. Fitzgerald, Theodore Lagattuta et al. · Clinical Pharmacology & Therapeutics · 2004 · 254 citations

Phase I and Pharmacokinetic Study of Vorinostat, A Histone Deacetylase Inhibitor, in Combination with Carboplatin and Paclitaxel for Advanced Solid Malignancies

Suresh S. Ramalingam, Robert A. Parise, Ramesh K. Ramananthan et al. · Clinical Cancer Research · 2007 · 196 citations · Full text

Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD 2 F 1 mice and Fischer 344 rats

Merrill J. Egorin, Theodore Lagattuta, Deborah R. Hamburger et al. · Cancer Chemotherapy and Pharmacology · 2002 · 175 citations

Pharmacological Study, Biochemistry, Medicine +6

Pharmacokinetics and pharmacodynamics of 17-demethoxy 17-[[(2-dimethylamino)ethyl]amino]geldanamycin (17DMAG, NSC 707545) in C.B-17 SCID mice bearing MDA-MB-231 human breast cancer xenografts

Julie L. Eiseman, Jing Lan, Theodore Lagattuta et al. · Cancer Chemotherapy and Pharmacology · 2004 · 150 citations

C.b-17 Scid Mice, Pharmaceutical Science, Biochemistry +6